Crestchem Limited (BOM:526269)
India · Delayed Price · Currency is INR 92.10
-3.40 (-3.56%)
At close: Apr 20, 2026
Crestchem Market Cap
Crestchem has a market cap or net worth of 276.3 million as of April 20, 2026. Its market cap has decreased by -57.18% in one year.
Market Cap
276.30M
Enterprise Value
265.84M
Revenue
266.14M
Ranking
n/a
PE Ratio
12.42
Stock Price
92.10
Market Cap Chart
Since November 1, 2012, Crestchem's market cap has increased from 31.23M to 276.30M, an increase of 784.73%. That is a compound annual growth rate of 17.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 276.30M | -18.10% |
| Dec 31, 2025 | 337.35M | -59.85% |
| Dec 31, 2024 | 840.15M | 239.45% |
| Dec 29, 2023 | 247.50M | 38.66% |
| Dec 30, 2022 | 178.50M | 35.69% |
| Dec 31, 2021 | 131.55M | -13.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smruthi Organics | 1.37B |
| Tyche Industries | 1.32B |
| Krebs Biochemicals & Industries | 1.31B |
| Resonance Specialties | 1.14B |
| Bacil Pharma | 775.21M |
| Alfavision Overseas (India) | 510.72M |
| Vasundhara Rasayans | 420.32M |
| Venmax Drugs and Pharmaceuticals | 301.74M |